Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisation
The clinical development of the meningococcal vaccine, 4CMenB, included 2 doses in vaccine-naïve adolescents, which was considered unlikely to be cost-effective for implementation. Theoretically, priming with 4CMenB in early childhood might drive strong immune responses after only a single booster d...
Huvudupphovsmän: | Rollier, CS, Dold, C, Blackwell, L, Linder, A, Silva-Reyes, L, Clutterbuck, E, Davis, K, Ford, K, Liu, X, Holland, A, Chan, H, Harbinson, H, O'Connor, D, Borrow, R, Snape, MD, Pollard, AJ |
---|---|
Materialtyp: | Journal article |
Språk: | English |
Publicerad: |
Elsevier
2022
|
Liknande verk
Liknande verk
-
The effect of a single 4CMenB vaccine booster in young people more than ten years after infant immunisation: protocol of an exploratory immunogenicity study
av: Davis, K, et al.
Publicerad: (2019) -
The capsular group B meningococcal vaccine, 4CMenB : clinical experience and potential efficacy.
av: Rollier, C, et al.
Publicerad: (2014) -
Comparative transcriptomics between species attributes reactogenicity pathways induced by the capsular group B meningococcal vaccine, 4CMenB, to the membrane-bound endotoxin of its outer membrane vesicle component.
av: Sheerin, D, et al.
Publicerad: (2019) -
4CMenB journey to the 10-year anniversary and beyond
av: Véronique Abitbol, et al.
Publicerad: (2024-12-01) -
Evaluation of strain coverage of the multicomponent meningococcal serogroup B vaccine (4CMenB) administered in infants according to different immunisation schedules
av: Alessia Biolchi, et al.
Publicerad: (2019-03-01)